Should intravesical Bacillus Calmette–Guerin (BCG) treatment be administered to patients with T0 after repeat transurethral resection of bladder tumor in patients with high-risk non-muscle invasive bladder cancer?

We evaluated the effect of intravesical Bacillus Calmette–Guerin (BCG) and BCG maintenance therapy on the prognosis of patients with T0 after repeat transurethral resection of bladder mass (TURBT). This retrospective analysis involved 427 patients who underwent repeat TURBT within 6 weeks after init...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuk, Hyeong Dong, Jeong, Chang Wook, Kwak, Cheol, Kim, Hyeon Hoe, Ku, Ja Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264801/
https://www.ncbi.nlm.nih.gov/pubmed/30496283
http://dx.doi.org/10.1371/journal.pone.0208267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264801/
https://www.ncbi.nlm.nih.gov/pubmed/30496283
http://dx.doi.org/10.1371/journal.pone.0208267

Ejemplares similares